Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease

Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease

Tolerogenic vaccines are aimed at inhibiting antigen-specific immune responses. Antigen-loaded nanoparticles (NPs) have been recently emerged as ideal tools for tolerogenic vaccination because their composition, size, and capability of loading immunomodulatory molecules can be readily exploited to i...

Full description

Bibliographic Details
Main Authors: Giuseppe Cappellano, Cristoforo Comi, Annalisa Chiocchetti, Umberto Dianzani
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:International Journal of Molecular Sciences
Subjects:
nanoparticle
PLGA
tolerogenic vaccination
inverse adjuvant
Online Access:http://www.mdpi.com/1422-0067/20/1/204

Internet

http://www.mdpi.com/1422-0067/20/1/204

Similar Items